Inventor · disambiguated record
Gretchen Snyder
Also filed as: SNYDER GRETCHEN · SNYDER GRETCHEN L
22 granted patents·16 pending applications·275 citations·filing 1997–2025
95Inventor score
Top patents by PatentIndex Score
38 records- 0198US12023331B2MethodsINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Jul 2, 2024·10 cites·26 claims
- 0298US11844757B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Dec 19, 2023·10 cites·14 claims
- 0398US11773095B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2022·Granted Oct 3, 2023·9 cites·21 claims
- 0498US11427587B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Aug 30, 2022·31 cites·13 claims
- 0598US10799500B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Oct 13, 2020·28 cites·17 claims
- 0698US10245260B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2017·Granted Apr 2, 2019·38 cites·15 claims
- 0797US11980617B2Methods of treating acute depression and/or acute anxietyINTRA CELLULAR THERAPIES INC·Filed 2019·Granted May 14, 2024·17 cites·35 claims
- 0897US11376249B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Jul 5, 2022·29 cites·19 claims
- 0994US12173004B2Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugsINTRA CELLULAR THERAPIES INC·Filed 2023·Granted Dec 24, 2024·1 cites·24 claims
- 1088US9157906B2Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brainGREENGARD PAUL·Filed 2010·Granted Oct 13, 2015·21 cites·4 claims
- 1187US12496300B2Methods of treating acute depression and anxietyINTRA CELLULAR THERAPIES INC·Filed 2024·Granted Dec 16, 2025·0 cites·27 claims
- 1285US12440489B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2023·Granted Oct 14, 2025·0 cites·17 claims
- 1385US12409176B2Methods of treating acute depressionINTRA CELLULAR THERAPIES INC·Filed 2024·Granted Sep 9, 2025·0 cites·11 claims
- 1484US6013621AMethod of treating psychosis and/or hyperactivityUNIV ROCKEFELLER·Filed 1997·Granted Jan 11, 2000·71 cites·5 claims
- 1580US12396992B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Aug 26, 2025·1 cites·22 claims
- 1678US11291666B2UsesINTRA CELLULAR THERAPIES INC·Filed 2017·Granted Apr 5, 2022·3 cites·11 claims
- 1778US10105349B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Oct 23, 2018·2 cites·5 claims
- 1878US9849132B2Products and pharmaceutical compositionsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Dec 26, 2017·3 cites·10 claims
- 1977US2024307386A1Novel methodsINTRA CELLULAR THERAPIES INC·Filed 2024·Application pending·0 cites
- 2070US10300064B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted May 28, 2019·1 cites·8 claims
- 2169US2022296591A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2022·Application pending·0 cites
- 2268US2025312340A1Methods of treating neuropathic painINTRA CELLULAR THERAPIES INC·Filed 2025·Application pending·0 cites
- 2368US2025339438A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2025·Application pending·0 cites
- 2465US2023372336A1Novel methodsINTRA CELLULAR THERAPIES INC·Filed 2023·Application pending·0 cites
- 2565US2025195510A1Novel methodsINTRA CELLULAR THERAPIES INC·Filed 2023·Application pending·0 cites
- 2665US2025186446A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2023·Application pending·0 cites
- 2762US12478623B2Methods of treating central nervous system disorders comprising administering lumateperone and a nitric oxide donorINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Nov 25, 2025·0 cites·12 claims
- 2862US2025101029A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2023·Application pending·0 cites
- 2962US2025320214A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2023·Application pending·0 cites
- 3061US2024415832A1Novel methodsINTRA CELLULAR THERAPIES INC·Filed 2022·Application pending·0 cites
- 3160US12414948B2MethodsINTRA CELLULAR THERAPIES INC·Filed 2023·Granted Sep 16, 2025·0 cites·27 claims
- 3257US2022184072A1Methods of treating neuropathic painINTRA CELLULAR THERAPIES INC·Filed 2020·Application pending·0 cites
- 3357US2024009195A1Novel usesINTRA CELLULAR THERAPIES INC·Filed 2021·Application pending·0 cites
- 3455US2008176961A1Phosphodiesterase acitvity and regulation of phosphodiesterase 1-B-mediated signaling in brainUNIV ROCKEFELLER·Filed 2007·Application pending·0 cites
- 3554US10543194B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Jan 28, 2020·0 cites·5 claims
- 3649US2022088014A1Methods of treating addictionINTRA CELLULAR THERAPIES INC·Filed 2020·Application pending·0 cites
- 3746US2003211040A1Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brainFiled 2002·Application pending·0 cites
- 3844US2021338679A1Novel usesINTRA CELLULAR THERAPIES INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →